Delivery Order SPE2DB20D1004-SPE2DB25FNEWU
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$7.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $8,538.80 firm fixed-price delivery order is for the supply of 4566133902 IPOL VIAL 5ML medical products, with an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with ID SPE2DB20D1050|SPE2DB25FH39K, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,819.65 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML medical products, with a completion date of December 4, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,067.35 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML, with a period of performance through August 5, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is a delivery order worth $20,920.06 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, awarded by the Defense Logistics Agency (DLA). The contract is for the delivery of IPOL VIAL 5ML medical supplies with a performance period through September 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,280.82 firm fixed price delivery order is for the supply of 4565736275 ! IPOL VIAL 5ML medical products. This award is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which...
This federal contract award, with an ID of SPE2DX15D3402|SPE2DX25F1KEZ, is a delivery order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,102.95 firm fixed-price contract is for the delivery of 4566760278 IPOL VIAL 5ML medical supplies, with a completion date of December 19, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award (#SPE2DB20D7059|SPE2DB24FQHE8) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,067.30 firm fixed-price delivery order is for the supply of IPOL VIAL 5ML, a pharmaceutical product, with a completion date of June 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,426.13 firm fixed-price delivery order is for the provision of IPOL VIAL 5ML medical products, with a performance period through December 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $3,415.52 firm-fixed-price delivery order is for the supply of 4564730251 IPOL VIAL 5ML, with a period of performance ending on May 29, 2024. This contract is not set aside and is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award with ID SPE2DB24D1034|SPE2DB25FWAF5 was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The $2,180.20 firm fixed-price delivery order contract covers the supply of IPOL VIAL 5ML medical products to support federal healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...